News Insights
Regulatory updates, industry headlines and supply-chain alerts, reviewed before publishing.
Advertise Here
Reach qualified buyersBoost your visibility among pharma sourcing professionals and potential buyers.
- Grow your business with qualified leads
- GDS reports on your ad performance
- Targeted to this product's audience
- Direct enquiries from buyers
- Visibility to pharma professionals
Latest news
Showing 37–48 of 94 stories
ADCAN, MS Pharma Plan UAE Production of Cancer and Chronic-Disease Medicines
The agreement covers injectables, tablets and biosimilars. ADCAN also plans UAE laboratory capacity for monoclonal-antibody quality testing.
FDA Classifies Apothecary Pharma's Tirzepatide Recall as Class II
The U.S. recall began Sept. 24 and includes 22 tirzepatide lots and one lot of Apothecary NAD+ Injection.
HSE could be saving nearly €150m annually by using more biosimilar drugs
Swiss pharma firm Sandoz highlights potential savings Ireland could make on medicines bill
Lilly, Mubadala Bio announce landmark deal to advance pharmaceutical manufacturing in Abu Dhabi
The partnership will be supported from a 125,000 sqm site in KEZAD, Abu Dhabi
FDA Approves GSK's Hibsago For Chronic Hepatitis B In Adults Without Cirrhosis
LONDON (dpa-AFX) - GSK plc (GSK) announced that the US Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen) to treat chronic…
Zydus Lifesciences Partners Prolific Machines for Biologics Manufacturing
Zylidac Bio, a CDMO within the Zydus Lifesciences group, has partnered with Prolific Machines to scale Prolific's next-generation biologics…
FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment
FDA today approved Hibsago (bepirovirsen) injection, in combination with existing antiviral therapy, to treat chronic hepatitis B virus (HBV)…
Sun Pharma’s UNLOXCYT gets NCCN Category 2A recommendation for locally advanced skin cancer
The updated recommendation adds to the drug’s existing Category 2A designation for metastatic cutaneous squamous cell carcinoma
Hikma Pharmaceuticals Spotlights R&D Shift, Nasal Epinephrine Filing Progress
Hikma Pharmaceuticals (LON:HIK) outlined a more centralized research and development strategy at the first event in its R&D Spotlight series…
Beyond the peptide hype: Which treatments have FDA approval?
Peptides have become a popular topic in the health and wellness world. You may have heard claims that peptide products can help you lose weight…
ADCAN Pharma, MS Pharma partner to advance Pharmaceutical localisation in UAE
ABU DHABI, 20th October, 2026 (WAM) -- ADCAN Pharma, a UAE-based pharmaceutical manufacturer, and MS Pharma, a leading regional biopharmaceutical…
Page 4 of 8
Advertise on PharmaJungle - Free for 30 Days
Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.
- 30 days of free advertising
- Visibility across all pages
- Performance report with ad insights
- No setup or registration fee
Exclusive introductory offer for new advertisers
Top sources
Post your requirement
Get offers from suppliers
- Reach pharmaceutical suppliers
- Specify quality standard and quantity
- Set your shipping preference
- Receive offers directly
- Listed on our marketplace
Your product details and requirements may be published on the marketplace.
Create a New Buying Request
Fields marked with * are mandatory.